Today PLX ranks # as SELL CANDIDATE.
Today PLX ranks # as SELL CANDIDATE.

PLX stock Protalix BioTherapeutics Inc

PLX stock
Protalix BioTherapeutics Inc

April 24, 2019
Change -0.94%
Chart period: 2019-01-25 - 2019-04-24





Social Sentiment for PLX

Today's data is from 4 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment -0.14

Will PLX stock price go up or down on Fri, 26 Apr 2019?

Protalix BioTherapeutics Inc Forecast and Stock Analysis

Technical PLX stock analysis for April 24, 2019.

Sell candidate since 2019-04-15 Loss -2.33%
Shorts 5.16% ( 2019-03-29 )
Cash n/a
Loans n/a
Beta 2.37
ROA -40.62

Protalix BioTherapeutics Inc fell by -0.94% in the last day from $0.42 to $0.42 The price has been going up and down for this period, and there has been a -4.55% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -16 457 shares and in total 152 774 shares bought and sold for approximately $64 165.10.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the PLX stock was $0.42. This is 0.94% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 5.00% from a day low at $0.40 to a day high of $0.42.

30 day high of the PLX stock price was $0.48 and low was $0.40.
90 day high was $0.60 and low was $0.39.
52 week high for the Protalix BioTherapeutics Inc - $0.83 and low - $0.27.


Protalix BioTherapeutics Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.01% during the next 3 months and, with 90% probability hold a price between $0.34 and $0.46 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Protalix BioTherapeutics Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.42 and $0.44. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 46 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Protalix BioTherapeutics Inc finds support from accumulated volume at $0.42.

Support: $0.42 Price: $0.42 Resistance: $0.48


In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Strong Sell Candidate

Protalix BioTherapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Today PLX ranks # as SELL CANDIDATE.
Today PLX ranks # as SELL CANDIDATE.